NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Individualized immunosuppression in organ transplant recipients based on real world evidence and artificial intelligence
Individualized immunosuppression in organ transplant recipients based on real world evidence and artificial intelligence is a funding opportunity from NEW YORK UNIVERSITY SCHOOL OF MEDICINE, up to 847371, closing July 31, 2030.
Jul 31, 2030
(1461d left)Overview
PROJECT SUMMARY Over 250,000 kidney transplant (KT) recipients depend on lifelong immunosuppressive therapy to prevent rejection and graft failure. However, immunosuppression increases the risk of complications such as infections, cancer, and cardiovascular disease (CVD), which together account for 70% of deaths in KT…